Clinical trial
Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer
NCT00004915 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00004915 |
|---|---|
| Title | Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer |
| Official title | Phase II Study of Raloxifene in Recurrent Endometrial Cancer |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometrial Cancer |
| Intervention type | Drug |
| Interventions | raloxifene |
| Start date | Nov 1, 1998 |
| Primary completion | Feb 1, 2000 |
| Completion | Feb 1, 2000 |
| First posted | Aug 30, 2004 |
| Last update posted | Jun 6, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: